Proellochs, N. I., Andolina, C., Ramjith, J., Stoter, R., van Gemert, G.-J., Graumans, W., Campino, S., Vanheer, L. N., Okitwi, M., Tumwebaze, P. K., Conrad, M. D., Clark, T. G., Fidock, D. A., Ménard, D., Mok, S., & Bousema, T. (2025). Gametocyte production and transmission fitness of African and Asian Plasmodium falciparum isolates with differential susceptibility to artemisinins. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01930-24

Rosado-Quiñones, A. M., Colón-Lorenzo, E. E., Pala, Z. R., Bosch, J., Kudyba, K., Kudyba, H., Leed, S. E., Roncal, N., Baerga-Ortiz, A., Roche-Lima, A., Gerena, Y., Fidock, D. A., Roth, A., Vega-Rodríguez, J., & Serrano, A. E. (2024). Novel hydrazone compounds with broad-spectrum antiplasmodial activity and synergistic interactions with antimalarial drugs. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01643-23

Strizki, J. M., Gaspar, J. M., Howe, J. A., Hutchins, B., Mohri, H., Nair, M. S., Kinek, K. C., McKenna, P., Goh, S. L., & Murgolo, N. (2024). Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistance. Antimicrobial Agents and Chemotherapy, 68(1). https://doi.org/10.1128/aac.00953-23

DeLaurentis, C. E., Kiser, J., & Zucker, J. (2022). New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human Monkeypox Virus. Antimicrobial Agents and Chemotherapy, 66(12). https://doi.org/10.1128/aac.01226-22

Zhang, J., Chen, L., Gomez-Simmonds, A., Yin, M. T., & Freedberg, D. E. (2022). Antibiotic-Specific Risk for Community-Acquired Clostridioides difficile Infection in the United States from 2008 to 2020. Antimicrobial Agents and Chemotherapy, 66(12). https://doi.org/10.1128/aac.01129-22

Kanai, M., Yeo, T., Asua, V., Rosenthal, P. J., Fidock, D. A., & Mok, S. (2022). Comparative Analysis of Plasmodium falciparum Genotyping via SNP Detection, Microsatellite Profiling, and Whole-Genome Sequencing. Antimicrobial Agents and Chemotherapy, 66(1). https://doi.org/10.1128/aac.01163-21

McConville, T. H., Austin, E. D., Geng, W., Shi, Q., Balasubramanian, D., Kubin, C. J., Torres, V. J., & Uhlemann, A.-C. (2022). In Vitro Cytotoxicity and Clinical Correlates of MRSA Bacteremia. Antimicrobial Agents and Chemotherapy, 66(1). https://doi.org/10.1128/aac.01559-21

Paloque, L., Coppée, R., Stokes, B. H., Gnädig, N. F., Niaré, K., Augereau, J.-M., Fidock, D. A., Clain, J., & Benoit-Vical, F. (2022). Mutation in the Plasmodium falciparum BTB/POZ Domain of K13 Protein Confers Artemisinin Resistance. Antimicrobial Agents and Chemotherapy, 66(1). https://doi.org/10.1128/aac.01320-21

Anahtar, M. N., Bramante, J. T., Xu, J., Desrosiers, L. A., Paer, J. M., Rosenberg, E. S., Pierce, V. M., & Kwon, D. S. (2022). Prediction of Antimicrobial Resistance in Clinical Enterococcus faecium Isolates Using a Rules-Based Analysis of Whole-Genome Sequences. Antimicrobial Agents and Chemotherapy, 66(1). https://doi.org/10.1128/aac.01196-21